Article
- The EMBO Journal (2005) 24, 2543 - 2555
- doi:10.1038/sj.emboj.7600729
Published online: 30 June 2005
Subject Category:
Repression of Runx2 function by TGF-
through recruitment of class II histone deacetylases by Smad3
Jong Seok Kang1, Tamara Alliston1, Rachel Delston1 and Rik Derynck1
- Department of Cell and Tissue Biology, Department of Anatomy, Programs in Cell Biology and Developmental Biology, University of California, San Francisco, CA, USA
Correspondence to:
Rik Derynck, Department of Cell and Tissue Biology, Programs in Cell Biology and Developmental Biology, University of California, San Francisco, CA 94143-0512, USA. Tel.: +1 415 476 7322; Fax: +1 415 476 1499; E-mail: derynck@itsa.ucsf.edu
Received 11 January 2005; Accepted 3 June 2005
Abstract
Transforming growth factor-
(TGF-
) inhibits osteoblast differentiation through inhibition of the function of Runx2 (Cbfa1) by Smad3. The mechanism through which TGF-
/Smad3 inhibits Runx2 function has not been characterized. We show that TGF-
induces histone deacetylation, primarily of histone H4, at the osteocalcin promoter, which is repressed by TGF-
, and that histone deacetylation is required for repression of Runx2 by TGF-
. This repression occurs through the action of the class IIa histone deacetylases (HDAC)4 and 5, which are recruited through interaction with Smad3 to the Smad3/Runx2 complex at the Runx2-binding DNA sequence. Accordingly, HDAC4 or 5 is required for efficient TGF-
-mediated inhibition of Runx2 function and is involved in osteoblast differentiation. Our results indicate that class IIa HDACs act as corepressors for TGF-
/Smad3-mediated transcriptional repression of Runx2 function in differentiating osteoblasts and are cell-intrinsic regulators of osteoblast differentiation.
Keywords:
- CBFA1,
- chromatin remodeling,
- mesenchymal differentiation,
- osteoblast,
- transcription
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Genesis of dendritic spines: insights from ultrastructural and imaging studies
Nature Reviews Neuroscience Review (01 Jan 2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Nature Review (09 Oct 2003)
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene Original Article
The EMBO Journal Article (01 May 2001)
The type I TGF-β receptor is covalently modified and regulated by sumoylation
Nature Cell Biology Article (01 Jun 2008)



